To overcome these obstacles and to further validate METCAM/MUC18 as a diagnosis marker for the cancer, the purpose of this research was to improve and modify the traditional LFIA test to increase the sensitivity and specificity of the assay by taking advantage of the extremely high affinity between biotin and streptavidin [20]. The gene discussed is MCAM; the disease is cancer.